Hepatitis E Virus Methyltransferase Inhibits Type I Interferon Induction by Targeting RIG-I

키워드

참고문헌 (92)

1. Aggarwal R, "Epidemiology of hepatitis E: current status", J. Gastroenterol. Hepatol., 24, pp.1484~1493 (2009)[DOI]
2. Arankalle VA, "Type-IV Indian swine HEV infects rhesus monkeys", J. Viral Hepat., 13, pp.742~745 (2006)[DOI]
3. Teshale EH, "The two faces of hepatitis E virus", Clin. Infect. Dis., 51, pp.328~334 (2010)[DOI]
4. Naik SR, "A large waterborne viral hepatitis E epidemic in Kanpur, India", Bull. World Health Organ., 70, pp.597~604 (1992)
5. Ricci A, "Public health risks associated with hepatitis E virus (HEV) as a food-borne pathogen", EFSA J., 15 (2017)
6. Jilani N, "Hepatitis E virus infection and fulminant hepatic failure during pregnancy", J. Gastroenterol. Hepatol., 22, pp.676~682 (2007)[DOI]
7. Navaneethan U, "Hepatitis E and pregnancy: understanding the pathogenesis", Liver Int., 28, pp.1190~1199 (2008)[DOI]
8. Pavio N, "Zoonotic origin of hepatitis E", Curr. Opin. Virol., 10, pp.34~41 (2015)[DOI]
9. Meng XJ, "Hepatitis E virus: animal reservoirs and zoonotic risk", Vet. Microbiol., 140, pp.256~265 (2010)[DOI]
10. Tam AW, "Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome", Virology, 185, pp.120~131 (1991)[DOI]
11. Koonin EV, "Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses", Proc. Natl. Acad. Sci. USA, 89, pp.8259~8263 (1992)[DOI]
12. Graff J, "A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus", J. Virol., 80, pp.5919~5926 (2006)[DOI]
13. Ropp SL, "Expression of the hepatitis E virus ORF1", Arch. Virol., 145, pp.1321~1337 (2000)[DOI]
14. Sehgal D, "Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein", Virol. J., 3, pp.38~ (2006)[DOI]
15. Suppiah S, "Lack of processing of the expressed ORF1 gene product of hepatitis E virus", Virol. J., 8, pp.245~ (2011)[DOI]
16. Graff J, "Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles", J. Virol., 82, pp.1185~1194 (2008)[DOI]
17. Shiota T, "The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilization", J. Virol., 87, pp.6031~6036 (2013)[DOI]
18. Qi Y, "Hepatitis E virus produced from cell culture has a lipid envelope", PLoS One, 10, pp.e0132503~ (2015)[DOI]
19. Yamada K, "ORF3 protein of hepatitis E virus is essential for virion release from infected cells", J. Gen. Virol., 90, pp.1880~1891 (2009)[DOI]
20. Nagashima S, "A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells", J. Gen. Virol., 92, pp.269~278 (2011)[DOI]
21. Kenney SP, "The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release", J. Virol., 86, pp.5637~5646 (2012)[DOI]
22. Nair VP, "Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus", PLoS Pathog., 12, pp.e1005521~ (2016)[DOI]
23. Theofilopoulos AN, "Type I interferons (alpha", beta) in immunity and autoimmunity, 2005, pp.23, 307~336
24. Xi Y, "Role of novel type I interferon epsilon in viral infection and mucosal immunity", Mucosal. Immunol., 5, pp.610~622 (2012)[DOI]
25. Zitvogel L, "Type I interferons in anticancer immunity", Nat. Rev. Immunol., 15, pp.405~414 (2015)[DOI]
26. 강상민, "Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas", The Journal of Microbiology, 55(5), pp.319~329 (2017), 한국미생물학회
27. Yarilina A, "Type I interferon: a new player in TNF signaling", Curr. Dir. Autoimmun., 11, pp.94~104 (2010)
28. Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)[DOI]
29. Medzhitov R, "Recognition of microorganisms and activation of the immune response", Nature, 449, pp.819~826 (2007)[DOI]
30. Fujita T, "Triggering antiviral response by RIG-I-related RNA helicases", Biochimie, 89, pp.754~760 (2007)[DOI]
31. Kawai T, "IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction", Nat. Immunol., 6, pp.981~988 (2005)[DOI]
32. Meylan E, "Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus", Nature, 437, pp.1167~1172 (2005)[DOI]
33. Seth RB, "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3", Cell, 122, pp.669~682 (2005)[DOI]
34. Hardy MP, "Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene", Biochem. J., 380, pp.83~93 (2004)[DOI]
35. Yamamoto M, "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway", Science, 301, pp.640~643 (2003)[DOI]
36. Fitzgerald KA, "IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway", Nat. Immunol., 4, pp.491~496 (2003)
37. Chau TL, "Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?", Trends Biochem. Sci., 33, pp.171~180 (2008)[DOI]
38. Hacker H, "Regulation and function of IKK and IKK-related kinases", Sci. STKE, 2006, pp.re13~ (2006)
39. Gatot JS, "Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK", I-TRAF, 2007, pp.282, 31131~31146
40. Clement JF, "The IKK-related kinases: from innate immunity to oncogenesis", Cell Res., 18, pp.889~899 (2008)[DOI]
41. Grandvaux N, "Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes", J. Virol., 76, pp.5532~5539 (2002)[DOI]
42. Honda K, "IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors", Nat. Rev. Immunol., 6, pp.644~658 (2006)[DOI]
43. Liu S, "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science, 347, pp.aaa2630~ (2015)[DOI]
44. Honda K, "IRF-7 is the master regulator of type-I interferon-dependent immune responses", Nature, 434, pp.772~777 (2005)[DOI]
45. Hiscott J, "Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis", Ann. NY Acad. Sci., 1010, pp.237~248 (2003)[DOI]
46. Wang J, "NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication", J. Immunol., 185, pp.1720~1729 (2010)[DOI]
47. Song JW, "Type I interferons function as autocrine and paracrine factors to induce autotaxin in response to TLR activation", PLoS One, 10 (2015)
48. Hu J, "LPS Regulates SOCS2 transcription in a type I interferon dependent autocrine-paracrine loop", PLoS One, 7 (2012)
49. Draenert R, "Virus immune evasion: new mechanism and implications in disease outcome", Adv. Virol., 2012, pp.490549~ (2012)
50. Senba M, "Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection", Oncol. Rev., 6, pp.e17~ (2012)[DOI]
51. 위지민, "Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site", Journal of Microbiology and Biotechnology, 27(7), pp.1336~1344 (2017), 한국미생물·생명공학회[DOI]
52. Bode JG, "IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3", FASEB J., 17, pp.488~490 (2003)[DOI]
53. Lin W, "Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain", J. Virol., 80, pp.9226~9235 (2006)[DOI]
54. Taylor DR, "Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein", Science, 285, pp.107~110 (1999)[DOI]
55. Li K, "Immune evasion by hepatitis C virus NS3", 4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF, 2005, pp.102, 2992~2997
56. Li XD, "Hepatitis C virus protease NS3", 4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity, 2005, pp.102, 17717~17722
57. Kang SM, "Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment", FEBS Lett., 584, pp.4069~4076 (2010)[DOI]
58. Lan KH, "HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines", J. Hepatol., 46, pp.759~767 (2007)
59. 강상민, "Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms", Journal of Microbiology and Biotechnology, 27(10), pp.1727~1735 (2017), 한국미생물·생명공학회
60. Zhou X, "Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection", J. Viral. Hepat., 23, pp.294~304 (2016)[DOI]
61. Krain LJ, "Host immune status and response to hepatitis E virus infection", Clin. Microbiol. Rev., 27, pp.139~165 (2014)[DOI]
62. Nan Y, "Hepatitis E virus inhibits type I interferon induction by ORF1 products", J. Virol., 88, pp.11924~11932 (2014)[DOI]
63. Karpe YA, "Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease", J. Gen. Virol., 92, pp.2088~2092 (2011)[DOI]
64. Oshiumi H, "A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses", PLoS Pathog., 9, pp.e1003533~ (2013)[DOI]
65. Faysal Bin Hamid, "Characterization of Prototype Foamy Virus Infectivity in Transportin 3 Knockdown Human 293t Cell Line", Journal of Microbiology and Biotechnology, 27(2), pp.380~387 (2017), 한국미생물·생명공학회[DOI]
66. Myoung J, "Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus", J. Virol., 85, pp.9767~9777 (2011)[DOI]
67. Myoung J, "Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction", J. Virol. Methods., 174, pp.12~21 (2011)[DOI]
68. Myoung J, "Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells", Virology, 413, pp.1~11 (2011)[DOI]
69. Myoung J, "Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells", J. Clin. Invest., 121, pp.1130~1140 (2011)[DOI]
70. Johne R, "Thermal stability of hepatitis E virus as estimated by a cell culture method", Appl. Environ. Microbiol., 82, pp.4225~4231 (2016)[DOI]
71. Kang HS, "Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination", J. Neuroinflammation, 13, pp.133~ (2016)[DOI]
72. Ha S, "Infection models of human norovirus: challenges and recent progress", Arch. Virol., 161, pp.779~788 (2016)[DOI]
73. Cho M, "OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells", J. Gen. Virol., 96, pp.3635~3645 (2015)[DOI]
74. 이진무, "An Aptamer-Based Electrochemical Sensor That Can Distinguish Influenza Virus Subtype H1 from H5", Journal of Microbiology and Biotechnology, 27(11), pp.2037~2043 (2017), 한국미생물·생명공학회
75. 이진무, "A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase", Journal of Microbiology and Biotechnology, 27(11), pp.2070~2073 (2017), 한국미생물·생명공학회
76. 최슬기, "Recombinant Adeno-Associated Virus Expressing Truncated IK Cytokine Diminishes the Symptoms of Inflammatory Arthritis", Journal of Microbiology and Biotechnology, 27(10), pp.1892~1895 (2017), 한국미생물·생명공학회
77. 유주은, "Evaluation of Various Real-Time Reverse Transcription Quantitative PCR Assays for Norovirus Detection", Journal of Microbiology and Biotechnology, 27(4), pp.816~824 (2017), 한국미생물·생명공학회[DOI]
78. 신진수, "Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate", The Journal of Microbiology, 55(12), pp.979~983 (2017), 한국미생물학회[DOI]
79. 정호철, "Exploiting virus-like particles as innovative vaccines against emerging viral infections", The Journal of Microbiology, 55(3), pp.220~230 (2017), 한국미생물학회
80. 김지현, "Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192", The Journal of Microbiology, 54(7), pp.520~526 (2016), 한국미생물학회[DOI]
81. Yasmine Samy Elkholy, "Evaluation of a novel commercial quaternary ammonium compound for eradication of Mycobacteria, HCV and HBV in Egypt", The Journal of Microbiology, 54(1), pp.39~43 (2016), 한국미생물학회[DOI]
82. 김미주, "Development of a One-Step Duplex RT-PCR Method for the Simultaneous Detection of VP3", VP1 and VP1, Journal of Microbiology and Biotechnology, pp.2016, 26(8)[DOI]
83. Ahn HS, "Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus", Virology, 512, pp.187~193 (2017)[DOI]
84. Lee M, "Detection of viable murine norovirus using the plaque assay and propidium-monoazide-combined real-time reverse transcription-polymerase chain reaction", J. Virol. Methods, 221, pp.57~61 (2015)[DOI]
85. Gillen J, "A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses", J. Virol., 89, pp.4918~4931 (2015)[DOI]
86. Fu B, "Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses", J. Virol., 89, pp.195~207 (2015)[DOI]
87. 임소라, "Alterations in Acetylation of Histone H4 Lysine 8 and Trimethylation of Lysine 20 Associated with Lytic Gene Promoters during Kaposi’s Sarcoma-Associated Herpesvirus Reactivation", Journal of Microbiology and Biotechnology, 27(1), pp.189~196 (2017), 한국미생물·생명공학회[DOI]
88. Schemmerer M, "Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line", Viruses, 8 (2016)
89. Devhare PB, "Analysis of antiviral response in human epithelial cells infected with hepatitis E virus", PLoS One, 8, pp.e63793~ (2013)[DOI]
90. Malmgaard L, "Induction and regulation of IFNs during viral infections", J. Interferon. Cytokine Res., 24, pp.439~454 (2004)[DOI]
91. Loo YM, "Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity", J. Virol., 82, pp.335~345 (2008)[DOI]
92. Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)[DOI]

관련 논문AI추천